# Behavioral Science in Clinical Trials: Part 3 — Why Diversity Must Be Built Into Trial Design > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/behavioral-science-clinical-trials-diversity/ > **Published:** 2026-04-08T20:29:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:06:43-04:00 > **Clinical Summary:** Explore why behavioral science clinical trials diversity is crucial for accurate cannabis research and improved patient outcomes. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic [Clinical Trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/)Health EquityResearch MethodsPopulation HealthEvidence-Based Medicine Why This Matters [Cannabis clinical trials](https://cedclinic.com/cannabinoids-hormone-receptor-positive-breast-cancer/) have historically suffered from poor diversity, limiting generalizability of findings across different populations. Since cannabis response can vary significantly by genetics, metabolism, and social determinants of health, homogeneous trial populations may miss clinically relevant differences in efficacy and safety profiles. Clinical Summary The article discusses integrating behavioral science principles into clinical trial design to improve diversity and representation. For [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/), this is particularly relevant given that cannabis use patterns, stigma responses, and therapeutic outcomes can vary substantially across demographic groups. Current cannabis trials often underrepresent minority populations, older adults, and patients with complex comorbidities, potentially limiting the external validity of results for real-world clinical populations. Dr. Caplan’s Take “I’ve seen firsthand how cannabis response varies dramatically across my patient population — what works for a 25-year-old white male with anxiety may be completely inappropriate for a 65-year-old Black woman with the same condition. We need trials that actually reflect the diversity of patients we treat.” Clinical Perspective 🧠 Clinicians should critically evaluate the demographics of cannabis studies when applying findings to their diverse patient populations. When published trials lack demographic diversity, consider starting with more conservative dosing and closer monitoring, especially in populations underrepresented in the research. This gap reinforces the importance of individualized [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) rather than one-size-fits-all approaches. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Behavioral%20Science%20in%20Clinical%20Trials%3A%20Part%203%20%E2%80%94%20Why%20Diversity%20Must%20Be%20Built%20Into...%20%40drcaplan&url=https%3A//www.appliedclinicaltrialsonline.com/view/behavioral-science-clinical-trials-diversity-trial-design)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.appliedclinicaltrialsonline.com/view/behavioral-science-clinical-trials-diversity-trial-design)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Behavioral%20Science%20in%20Clinical%20Trials%3A%20Part%203%20%E2%80%94%20Why%20Diversity%20Must%20Be%20Built%20Into...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.appliedclinicaltrialsonline.com/view/behavioral-science-clinical-trials-diversity-trial-design)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.appliedclinicaltrialsonline.com/view/behavioral-science-clinical-trials-diversity-trial-design](https://www.appliedclinicaltrialsonline.com/view/behavioral-science-clinical-trials-diversity-trial-design) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [ACT Brief: Diversity Built Into Trial Design, AI Impact Across Trial Lifecycle, and Companion …](https://cedclinic.com/clinical-trial-diversity-ai-cannabis-research-design/) Learn about the latest strategies for incorporating diversity into clinical trial design and the role of AI in trial lifecycle management. [Read the ACT Brief](https://cedclinic.com/clinical-trial-diversity-ai-cannabis-research-design/) [Putting Patients First in Drug Development | Applied Clinical Trials Online](https://cedclinic.com/patient-centered-drug-development-cannabis-research/) Discover patient-centered approaches in [drug development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/) that emphasize diversity and inclusion for better therapeutic outcomes. [Explore Patient-Centered Development](https://cedclinic.com/patient-centered-drug-development-cannabis-research/) [Cannabis Health Research: New Findings for June 2026](https://cedclinic.com/cannabis-health-research-new-findings-for-june-2026/) Stay updated on the latest cannabis health research, including studies highlighting diversity and behavioral science in trials. [See New Research Findings](https://cedclinic.com/cannabis-health-research-new-findings-for-june-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).